Literature DB >> 26961589

Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.

Robert H Six1, Csilla Becskei2, Lori Carter3, Boyd Gale4, David R Young5, Sean P Mahabir6, Sara Chapin6, Melanie R Myers6.   

Abstract

Four studies were conducted to evaluate the speed of kill, effect on egg production, and efficacy in a simulated infested-home environment of a novel isoxazoline, sarolaner (Simparica™, Zoetis), against fleas on dogs. Individually identified and housed, purpose-bred Beagles were used in each study and were allocated randomly to groups based on pretreatment parasite counts. In two speed of kill studies, groups of dogs infested with 100 fleas prior to treatment were treated orally with placebo or sarolaner tablets providing the minimum dose of 2mg/kg and then re-infested with fleas weekly for five weeks post-treatment. Comb counts were conducted to determine the numbers of viable fleas at one to three, four, eight and 12h after treatment and each subsequent infestation. In the egg production study, sarolaner- and placebo-treated dogs were similarly challenged with fleas and at 48h after each infestation the dogs were housed for 20h in cages allowing the collection and counting of all flea eggs produced during this period. Collected eggs were incubated to evaluate hatch and development to adults. The last study used dogs housed in a flea-infested simulated-home environment. Dogs were allocated to treatment with either placebo or sarolaner tablets providing a dose of 2mg/kg once a month for three treatments. Flea infestations were assessed by comb counts (fleas were replaced on the dogs) on Days 14, 30, 44, 60, 74 and 90. The speed of kill studies demonstrated that a single 2mg/kg oral dose of sarolaner started killing fleas within three to four hours after treatment or subsequent re-infestations for up to a month, and achieved ≥98% control of fleas by eight hours after treatment or re-infestation for 28 days. In the study to assess effects on flea reproduction, a single oral treatment of sarolaner resulted in the complete cessation of egg-laying for 35 days. This rapid kill of fleas and inhibition of reproduction were confirmed in a simulated-home environment where the existing infestations were reduced by >95% within two weeks of the first treatment and eliminated from the dogs after two monthly doses.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ctenocephalides felis felis; Dog; Efficacy; Environmental; Flea; Isoxazoline; Oral; Reproduction; Sarolaner; Simparica™; Speed of kill

Mesh:

Substances:

Year:  2016        PMID: 26961589     DOI: 10.1016/j.vetpar.2016.02.026

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  Assessment of the efficacy of a topical combination of fipronil-permethrin (Frontline Tri-Act®/Frontect®) against egg laying and adult emergence of the cat flea (Ctenocephalides felis) in dogs.

Authors:  Frédéric Beugnet; Lénaïg Halos; Wilfried Lebon; Julian Liebenberg
Journal:  Parasite       Date:  2016-12-19       Impact factor: 3.000

2.  Evaluation of sarolaner and spinosad oral treatments to eliminate fleas, reduce dermatologic lesions and minimize pruritus in naturally infested dogs in west Central Florida, USA.

Authors:  Michael W Dryden; Michael S Canfield; Emily Niedfeldt; Amanda Kinnon; Kimberly Kalosy; Amber Smith; Kaitlin M Foley; Vicki Smith; Todd S Bress; Nicole Smith; Mike Endrizzi; Joyce Login
Journal:  Parasit Vectors       Date:  2017-08-17       Impact factor: 3.876

Review 3.  Efficacy and safety of sarolaner (Simparica®) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia.

Authors:  Raj Packianathan; Sally Colgan; Andrew Hodge; Kylie Davis; Robert H Six; Steven Maeder
Journal:  Parasit Vectors       Date:  2017-08-16       Impact factor: 3.876

4.  A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment.

Authors:  Sivaja Ranjan; David Young; Fangshi Sun
Journal:  Parasit Vectors       Date:  2018-07-03       Impact factor: 3.876

5.  Immediate and persistent efficacy of sarolaner (Simparica™) against Haemaphysalis elliptica on dogs.

Authors:  Josephus J Fourie; Julian E Liebenberg; Dionne Crafford; Robert Six
Journal:  Parasit Vectors       Date:  2019-09-05       Impact factor: 3.876

Review 6.  The Biology and Ecology of Cat Fleas and Advancements in Their Pest Management: A Review.

Authors:  Michael K Rust
Journal:  Insects       Date:  2017-10-27       Impact factor: 2.769

7.  Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.

Authors:  Kristina Kryda; Robert H Six; Kelly F Walsh; Susan J Holzmer; Sara Chapin; Sean P Mahabir; Melanie Myers; Tammy Inskeep; Jady Rugg; Blair Cundiff; Aleah Pullins; Michael Ulrich; John W McCall; Tom L McTier; Steven J Maeder
Journal:  Parasit Vectors       Date:  2019-09-11       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.